FARMINGDALE, N.Y.--(BUSINESS WIRE)--Mispro Biotech Services (“Mispro”), a preclinical services company specializing in integrated vivarium solutions, today announced expansion of its network of vivarium research facilities with the opening of an 18,000-square-foot facility in Broad Hollow Bioscience Park (“Broad Hollow”) in Farmingdale, NY. This is Mispro’s fifth facility in its network and its second in New York.
“New York is fast becoming one of the world’s leading biotech hubs and opening a location in Farmingdale is a unique and exciting opportunity for us to serve a diverse community of life sciences innovators in the Long Island area,” said Mispro CEO Philippe Lamarre. “Within 25 miles of our new facility, there are a number of universities with life sciences programs, several well-known and established biopharma organizations and incubators, and an increasing number of early-stage biotechs choosing to set up their operations outside of the Manhattan periphery,” adds Lamarre.
Mispro Biotech Services offers extensive experience in vivarium operations and services, having grown a network of managed vivarium facilities in key North American biotech hubs since its founding in 2003, including a facility in east Manhattan’s life sciences cluster that opened in 2010. Mispro supports multiple clients in its facilities, giving them access to research and animal housing space while Mispro provides all animal care, regulatory, and compliance services, including Mispro’s own Institutional Animal Care and Use Committee (IACUC).
“We’re thrilled to have Mispro at Broad Hollow,” said Broad Hollow Bioscience Park Executive Director, Greg Blyskal. “Vivarium access for in vivo studies is much desired, and an exciting amenity for the life sciences community we have in the greater-Farmingdale area. It’s also a great addition to our science park campus, where we offer lab and office space and have well-established affiliations with academic, state, and private research institutions with preclinical pipelines.”
In addition to offering access to vivarium space for nearby research organizations, Mispro hopes the expansive, state-of-the-art facility will be an attractive option for companies headquartered in and around New York City, including more established companies who may need space for overflow studies, breeding, or team development.
Mispro Senior Director of Operations Keith Astrofsky, DVM, adds, “what we accomplish with this new facility is creating a destination that is not only highly-effective for conducting in vivo studies, but one that also inspires collaboration and innovation amongst members of this dynamic community. A vivarium with ready access to adjoining lab space and conference rooms offers great flexibility in supporting a wide range of studies and research disciplines.”
Mispro’s Broad Hollow Bioscience Park vivarium research facility is now open and accepting clients.
About Mispro Biotech Services
Since 2003, Mispro Biotech
Services has offered biopharmaceutical and life science companies access
to state-of-the-art vivarium research space plus comprehensive
laboratory animal science services supporting preclinical drug
development. With a network of vivarium facilities conveniently located
in key biotech and life science clusters in the U.S. and Canada
including Cambridge, Mass., Farmingdale, N.Y., New York City, Research
Triangle Park, N.C. and Montreal, Mispro offers an affordable and
scalable option for research organizations who do not have access to a
vivarium but choose to conduct and control their own studies. In
2019-2020, Mispro is planning to expand in the U.S. as well as Europe.
About Broad Hollow Bioscience Park
Broad Hollow Bioscience
Park is a partnership between Cold Spring Harbor Laboratory (www.cshl.edu),
and The Research Foundation for the State University of New York (www.rfsuny.org).
BHBP is located in rural Long Island within an easy commute to the
research institutes of Cold Spring Harbor Laboratory, Brookhaven
National Laboratory, Stony Brook University, Feinstein Institute for
Medical Research of Northwell Health and New York City research
institutions.
